Grant name: Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products
Funding organization: National Institutes of Health (NIH)
Total funding amount: Not specified
Duration: UG3 phase up to 1 year, UH3 phase expected 4 years (up to 6 years with justification)
Primary objective: To study the effects of natural products in NCCIH designated areas of high research priority.
Key stakeholders: NIH, NCCIH, participating organizations, and research participants.
Funding source: Federal government.
Funding type: Cooperative agreement.
Significance: Addresses gaps in knowledge regarding the efficacy of natural products.
Grant frequency: One-time application for each cycle.
Higher Education Institutions (Public/State Controlled, Private)
Nonprofits (with and without 501(c)(3) status)
For-Profit Organizations (including Small Businesses)
Local, State, and Federal Governments
Indian/Native American Tribal Governments
Other (e.g., Independent School Districts, Public Housing Authorities)
Foreign organizations are not eligible to apply.
Natural products including botanicals, probiotics, and dietary supplements.
High research priority areas such as pain management, gastrointestinal disorders, and mental health.
Contribute to the evidence base for the efficacy of natural products.
Enhance understanding of the mechanisms of action of natural products.
Experience in conducting multi-site clinical trials.
Expertise in clinical trial design and data management.
Application budgets are not limited but must reflect actual project needs.
Combined budgets of CCC and DCC will determine direct costs policy.
Posted Date: February 02, 2024
Open Date: February 04, 2024
Application Due Dates: Various deadlines from March 2024 to July 2026.
Must adhere to FDA regulations for clinical research.
Investigators must determine if an Investigational New Drug (IND) application is necessary.
Plan for Enhancing Diverse Perspectives (PEDP).
Clinical trial project management plan.